24 February 2017
News and Views
Links and Services
April's issue of the Alimentary Pharmacology & Therapeutics evaluates the unique characteristics and evolving therapies in genotype 3.
Over the past several years, hepatitis C therapy has been pegylated interferon and ribavirin base
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors